top of page


ISPOR Europe 2022

GEECS Member, James Buchanan, moderated a panel "Addressing Equity Challenges In Genome Sequencing: What Can Health Economics Contribute?", with GEECS Members Deborah Marshall, Jeroen Jansen, and Maarten IJzerman as panelists at ISPOR Europe 2022 in Vienna, Austria on November 9, 2022.

USC Schaeffer Precision Medicine Panels

GEECS Chair, Kathryn Phillips, participated in a panel on Precision Medicine: Moving Theory into Practice at the USC Schaeffer Center for Health Policy & Economics on Tuesday, June 29th, 2021. This panel is part of a series of four webinars:

ECOgenomics Conference

Members of GEECS presented at the ECOgenomics Conference. The Health Economics Team of the Economics Laboratory of Dijon (University of Burgundy) organizes the "European Conference on the Diffusion of Genomic Medicine: Health Economics & Policy" on May 27th and 28th, 2021. This two-day symposium alternates plenary sessions and parallel thematic sessions and brings together researchers in the human sciences, mainly in health economics, but also researchers from other disciplines. It will contribute to the development of research in genomic medicine concerning its evaluation, its dissemination, and the public policies accompanying this new type of medicine.


Virtual Workshop

GEECS Members, Sarah Wordsworth and James Buchanan, presented at the HEcoPerMed Virtual Workshop on April 20, 2021. They presented on "Financing and Reimbursement for Personalized Medicine - the way forward."

17th H3Africa Consortium Meeting

GEECS Member, James Buchanan, presented at the 17th H3Africa Consortium Meeting on April 20, 2021. He presented on "Translating genome and exome sequencing into clinical practice in Africa: a health economics perspective." More details

University of Aberdeen, Health Economics Research Unit

GEECS Member, Dean Regier, presented at the University of Aberdeen's Health Economics Research Unit External Seminars Programme on April 22, 2021. He presented on "Resource allocation for genomics and rare disease diagnosis: where we were and next steps for evaluation." More details

bottom of page